scholarly article | Q13442814 |
P2093 | author name string | Becker TM | |
Kefford RF | |||
de la Pena A | |||
Leclercq IA | |||
Mann GJ | |||
Rizos H | |||
Woodruff S | |||
P433 | issue | 3 | |
P921 | main subject | NF-κB | Q411114 |
P304 | page(s) | 873-879 | |
P577 | publication date | 2005-07-01 | |
P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
P1476 | title | Impaired inhibition of NF-kappaB activity by melanoma-associated p16INK4a mutations | |
P478 | volume | 332 |
Q37308298 | Assessment of functional effects of unclassified genetic variants |
Q39564985 | Classifying variants of CDKN2A using computational and laboratory studies |
Q38985389 | Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151. |
Q30375327 | Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients. |
Q28291669 | Good cop, bad cop: the different faces of NF-kappaB |
Q33776852 | IKK is a therapeutic target in KRAS-Induced lung cancer with disrupted p53 activity |
Q42584249 | INK4a/ARF [corrected] inactivation with activation of the NF-κB/IL-6 pathway is sufficient to drive the development and growth of angiosarcoma |
Q80305797 | Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients |
Q36416479 | NF-kappaB activation in melanoma |
Q37149856 | Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth |
Q34683406 | p16 Protein and gigaxonin are associated with the ubiquitination of NFκB in cisplatin-induced senescence of cancer cells |
Search more.